Post-Mensing Landscape A Wasteland For Plaintiffs

Law360, New York (June 25, 2012, 8:28 PM EDT) -- One year after the U.S. Supreme Court's landmark Mensing decision, product liability suits against generic-drug manufacturers are all but dead, as plaintiffs have failed again and again to find ways to hold companies liable without now-preempted failure-to-warn claims, attorneys say.

The high court ruled in June 2011 that state-law failure-to-warn allegations against generics manufacturers are preempted by federal law because generic drugs are required to have the same warning label as brand-name drugs.

Experts predicted that the ruling could wipe out personal injury claims against generics...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.